Last checked at 21 Nov 2022 11:40
Craneware plc
("Craneware" or the "Company")
Grant of Long Term Incentive Plan Awards
21 November 2022 - The Board of Craneware plc (AIM: CRW.L), the market leader in Value Cycle software solutions for the US healthcare market, announces that on 18 November 2022, under the terms of the Craneware plc Long Term Incentive Plan (2022) ("LTIP"), a conditional award of ordinary shares of 1p each in the Company ("Shares") was granted to three Directors of the Company as follows:
Director | No. of Shares over which a conditional share award was granted | Percentage of issued share capital |
Keith Neilson (CEO) | 30,796 | 0.09% |
Craig Preston (CFO) | 22,890 | 0.06% |
Isabel Urquhart (CPO) | 15,734 | 0.04% |
The awards will ordinarily vest after three years subject to:
(i) the satisfaction of certain performance conditions (each with 50% weighting) based on: (a) the Company's total shareholder return ("TSR") performance relative to the performance achieved by the constituent companies within the FTSE AIM 100 Index; and (b) compound annual growth in adjusted diluted earnings per share, as reported in the consolidated financial statements of the Company and its subsidiaries; and
(ii) the Director's continued employment.
The performance conditions are measured in three tranches such that one third of the Shares over which the LTIP awards subsist will vest based on performance over the three years ending on 30 June 2023, one third based on performance over the three years ending 30 June 2024 and the final third based on performance over the three years to 30 June 2025 - an aggregate five year period. Any tranche (or part thereof) that does not meet the performance criteria will lapse.
If and to the extent that these LTIP awards vest, the resulting (net of tax) Shares will be subject to a two year holding period.
There was no consideration for the grant of the LTIP awards and no consideration will be payable by the award holders to receive the Shares from these LTIP awards, if and to the extent that they vest.
PDMR notification: Keith Neilson
1. Details of the Restricted Person / person closely associated with him or her
a) Name Keith Neilson
2. Reason for the notification
a) Position / status CEO
b) Initial notification / Amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Craneware plc
b) LEI 213800O2CTJ1YFXNXG05
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of
instrument Ordinary shares of 1p each in the capital of Craneware plc
b) Identification code ISIN GB00B2425G68
c) Nature of the transaction Grant of conditional share award under the Craneware plc
Long Term Incentive Plan (2022)
d) Price(s) and volume(s) Volume(s) granted 30,796, Price(s) £0
e) Aggregated information:
i. Aggregated volume Aggregate volume granted 30,796
ii. Price Price(s) £0
f) Date of the transaction 2022-11-18
g) Place of the transaction Outside a trading venue
PDMR notification: Craig Preston
1. Details of the Restricted Person / person closely associated with him or her
a) Name Craig Preston
2. Reason for the notification
a) Position / status CFO
b) Initial notification / Amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Craneware plc
b) LEI 213800O2CTJ1YFXNXG05
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of
instrument Ordinary shares of 1p each in the capital of Craneware plc
b) Identification code ISIN GB00B2425G68
c) Nature of the transaction Grant of conditional share award under the Craneware plc
Long Term Incentive Plan (2022)
d) Price(s) and volume(s) Volume(s) granted 22,890, Price(s) £0
e) Aggregated information:
i. Aggregated volume Aggregate volume granted 22,890
ii. Price Price(s) £0
f) Date of the transaction 2022-11-18
g) Place of the transaction Outside a trading venue
PDMR notification: Isabel Urquhart
1. Details of the Restricted Person / person closely associated with him or her
a) Name Isabel Urquhart
2. Reason for the notification
a) Position / status Chief People Officer
b) Initial notification / Amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Craneware plc
b) LEI 213800O2CTJ1YFXNXG05
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of
instrument Ordinary shares of 1p each in the capital of Craneware plc
b) Identification code ISIN GB00B2425G68
c) Nature of the transaction Grant of conditional share award under the Craneware plc
Long Term Incentive Plan (2022)
d) Price(s) and volume(s) Volume(s) granted 15,734, Price(s) £0
e) Aggregated information:
i. Aggregated volume Aggregate volume granted 15,734
ii. Price Price(s) £0
f) Date of the transaction 2022-11-18
g) Place of the transaction Outside a trading venue
For further information, please contact:
Craneware plc | +44 (0)131 550 3100 |
Keith Neilson, CEO | |
Craig Preston, CFO | |
| |
Alma (Financial PR) | +44 (0)20 3405 0205 |
Caroline Forde, Hilary Buchanan, Joe Pederzolli | craneware@almapr.co.uk |
| |
Peel Hunt (NOMAD and Joint Broker) | +44 (0)20 7418 8900 |
Dan Webster, Andrew Clark | |
| |
Investec Bank PLC (Joint Broker) | +44 (0)20 7597 5970 |
Patrick Robb, Henry Reast, Sebastian Lawrence | |
|
|
Berenberg (Joint Broker) | +44 (0)20 3207 7800 |
Mark Whitmore, Richard Andrews, Alix Mecklenburg-Solodkoff |
About Craneware
We at The Craneware Group of companies, including our latest additions Sentry Data Systems and Agilum Healthcare Intelligence, passionately believe we can impact healthcare profoundly by delivering the insights healthcare organisations need to also transform the business of healthcare. Our shared vision is to be the operational and financial partner for US healthcare providers.
Our combined suite of applications and industry-leading team of experts help our customers contextualise operational, financial, and clinical data, providing insights that clearly demonstrate what great looks like. These value cycle insights deliver revenue integrity and 340B compliance, as well as margin and operational intelligence- something no other single partner can provide.
Together, approximately 40% of registered US hospitals are now our customers, including more than 12,000 US hospitals, health systems and affiliated retail pharmacies and clinics. Our customers are operating with a financial impact of nearly half a trillion dollars. We have data sets from customers covering more than 150 million unique patients encounters.
Learn more at www.thecranewaregroup.com